Lipidio Pharmaceuticals
- Biotech or pharma, therapeutic R&D
Lipidio is focused on developing its topical drug candidate, GDD3898, a small molecule NCE, as a novel treatment for obesity. The drug acts by increasing energy expenditure with preclinical efficacy equivalent to GLP-1 agonists but without muscle loss,
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}